RE:SellingI bought this stock knowing that over the course of the past few years when EKG loans were coming to term that they released a few forward thinking and positive news releases only to deplete their current shareholder value by providing stock to their creditors rather than pay the outstanding debt. Grima is overpaid and hasn't truly created or provided any plausible shareholder value in the past few years. Sadly, I think the EKG stock will once again 'flatline' as it does every year and sit at 2.5 to 3 cents per share from late February until October, at which time, they will prepare a few more positive news releases to offset more loans coming to term.
Hopefully, I'm wrong about this, but it seems history seems to repeat itself with this company.